Machine Learning in Drug Discovery: Ava Amini @broadinstitute
Machine Learning in Drug Discovery: Ava Amini  @broadinstitute
Uploaded January 2026 | Updated November 2026, 3 days ago
Modeling and targeting cell states in cancer

Ava Amini
Microsoft Research

The Machine Learning in Drug Discovery Symposium was held on November 7, 2025 at the Broad Institute.

This hybrid symposium highlights recent progress in the application of machine learning techniques to drug discovery and brings together researchers working in applying machine learning to target validation, hit identification and optimization, clinical trial design, biologics, and other areas of drug discovery for talks, poster sessions and networking.

For questions about the symposium or interest in sponsoring the 2026 symposium, reach out to mlinddsymposium@broadinstitute.org.

For more information, visit: broadinstitute.org/machine-learning-drug-discovery-symposium/machine-learning-drug-discovery

Copyright Broad Institute, 2025. All rights reserved.
Machine Learning in Drug Discovery: Ava AminiThe role of intrinsically disordered regions in directing transcription factor binding vast genomes11th Annual Rare Disease Day Event: Ajamete KaykasHow AI and machine learning will transform biomedical research: Caroline UhlerAnna Greka: Core Institute Member #broadinstitute #raredisease #science #geneticsAI-Enabled Phenotypic Profiling of Parasite Infection Using Optical Pooled ScreeningBiological data in the age of AIVariant to Function (V2F) Symposium: Ruth Loos (2025)MPG Primer: Network-based rare variant association for complex diseases (2026)Generative Design of Cell Type-Specific RNA Splicing Elements for Programmable Gene RegulationMIA: Jean Fan, Comparative Spatial Transcriptomics; primer by Caleb HallinanMPG Primer: Iqbal Lab | The Genomics 2 Proteins Portal (2025)
Broad Institute |

Machine Learning in Drug Discovery: Ava Amini

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER